Biotechnology
Technology
Health

Compugen

$3.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (2.45%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Compugen and other stocks, options, ETFs, and crypto commission-free!

About

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. Read More The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Employees
89
Headquarters
Holon, Tel Aviv
Founded
1993
Market Cap
195.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
183.61K
High Today
$3.43
Low Today
$3.27
Open Price
$3.27
Volume
29.67K
52 Week High
$4.31
52 Week Low
$2.00

Collections

Biotechnology
Technology
Health
Research And Development
Asia (Non-China)
Asia
Female CEOs

Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.17 per share
Actual
-$0.14 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.